Login to Your Account



NewCo News

Versartis Spin-off Diartis Adds to GLP-1 Space with Series A

By Marie Powers


Tuesday, February 22, 2011
Privately held Diartis Pharmaceuticals Inc., a spin-off launched late last year from Versartis Inc., both of Mountain View, Calif., hit the ground running with a Series A financing from Index Ventures, biotech company Amunix Inc. and private investors.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription